Four in vivo studies showed that administration of CBG or 2-methoxy-5-amino-N-hydroxybenzamide to nude mice increased PERK arm activity, inhibited CRC progression, and ultimately reduced tumor size in animal models of CRC [35, 36]. Here, EIF2AK3 is linked to colorectal carcinoma.